Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2010
05/18/2010US7718686 Gastrointestinal disorders; irritable bowel syndrome
05/18/2010US7718676 E.g., Methyl 4-{[4-Methyl-3-(4-pyridin-3-yl-oxazol-2-ylamino)-phenylamino]-methyl}-benzoate; stem cell factor, bcr-abl, fibroblastic growth factor receptor-3 and Flt-3 inhibitors; treating rheumatoid arthritis, conjunctivitis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, transplant rejection
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718654 Substituted pteridines for the treatment of inflammatory diseases
05/18/2010US7718653 Pyrimidine derivatives for inhibiting Eph receptors
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2437754C Tablets quickly disintegrated in oral cavity
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/14/2010WO2010054398A1 Compounds useful as inhibitors of atr kinase
05/14/2010WO2010054078A1 Gamma secretase modulators
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010053861A2 Biologically active amides
05/14/2010WO2010053732A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052569A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010WO2010052199A1 Heterocyclic gamma secretase modulators
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010WO2009156484A3 Organic compounds
05/14/2010CA2743196A1 Heterocyclic gamma secretase modulators
05/14/2010CA2743134A1 Compounds useful as inhibitors of atr kinase
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2742317A1 Gamma secretase modulators
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010CA2741299A1 Isoindoline compounds for use in the treatment of cancer
05/13/2010US20100121070 Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds
05/13/2010US20100121062 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
05/13/2010US20100121052 Novel compounds for treating proliferative diseases
05/13/2010US20100121048 Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
05/13/2010US20100120876 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mc4) agonist peptide
05/13/2010US20100120864 2-aminooxazolines as taar1 ligands
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/13/2010US20100120800 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120775 Farnesoid X Receptor Agonists
05/13/2010US20100120769 Cyclohexyl piperazinyl methanone derivatives
05/13/2010US20100120764 Di-substituted amides for enhancing glutamatergic synaptic responses
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120760 Benzofuran-carboxamide derivatives as antiviral agents
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100120758 Reverse-turn mimetics and method relating thereto
05/13/2010US20100120757 Pyrazolone derivatives as pde4 inhibitors
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120739 Triazolopyridazine protein kinase modulators
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
05/13/2010US20100120721 Substituted piperidinophenyl oxazolidinones
05/13/2010US20100120717 Kinase inhibitors
05/13/2010US20100119622 3h-benzooxazol-2-one modulators of d2 receptor and/or 5-ht1a receptor
05/13/2010US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
05/13/2010US20100119479 Therapeutic antiviral peptides
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183247A1 New crystalline forms of 2 -hydroxy- 3- ý5- (morpholin- 4- ylmethyl) pyridin-2-yl¨ih- indole- 5 -carbonitrile citrate
05/12/2010EP2183246A2 2-aza-bicyclo-[3.3.0]-octane derivatives
05/12/2010EP2183245A2 Dual modulators of 5-ht2a and d3 receptors
05/12/2010EP2183237A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
05/12/2010EP2183234A1 Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
05/12/2010EP2183232A2 Pi3 kinase modulators and methods of use
05/12/2010EP2183229A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
05/12/2010EP2183228A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
05/12/2010EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP2182808A1 Pyridine compounds for inflammation and immune-related uses
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1794997B 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
05/12/2010CN101705245A Non-viral gene vector of poly-benzimidazole metal complex and preparation and application thereof
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704797A compounds effecting glucokinase
05/11/2010US7714150 Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714137 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide; Hepatitis C virus
05/11/2010US7714130 To a suspension of 2-(4-t-butylphenyl)-4-piperazin-1-yl-1H-benzimidazole and potassium carbonate in acetone was added 6-bromomethylquinoxaline to produce 2-(4-tert-butylphenyl)4-{[4-(6-quinoxalyl)methyl]piperazin-1-yl}benzimidazole Dihydrochloride Dihydrate
05/11/2010US7714128 crystalline linezolid form III (N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide) an antibacterial agent; thermal stability
05/11/2010US7714127 Process for making heteroaryl amine intermediate compounds
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7713987 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
05/11/2010US7713983 Voltage gated sodium and calcium channel inhibitors
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2598516C Benzisoxazole derivatives
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2393996C Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles
05/11/2010CA2378603C Benzofuran derivatives
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050461A1 Novel amide derivative and use thereof as medicine
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010049915A1 Poly-heteroaryl derivatives for the treatment of cancer
05/06/2010WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 647